Bard Associates »

Vertex Pharmaceuticals Incorporated shares owned by Bard Associates

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Bard Associates from 13F filings

Historical chart of Bard Associates investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Bard Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Bard Associates

Quarter filed Position value Share count Share price at filing
2025-12-31 $159k 350 453.36

More positions owned by Bard Associates

Ishares Tr Pfd And Incm Sec (PFF)
Flaherty & Crumrine/Claymore Preferred S (FFC)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Coherent Corp (COHR)
Vanguard Index Fds Real Estate Etf (VNQ)
Ishares Tr Residential Mult (REZ)
Vaneck Etf Trust Bdc Income Etf (BIZD)
Mamamancini's Holdings (MAMA)
Ensign (ENSG)
Alps Etf Tr Alerian Mlp (AMLP)
Tortoise Energy Infrastructure closed end funds (TYG)
Willdan (WLDN)
Kayne Anderson MLP Investment (KYN)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Nextera Energy (NEE)

View all positions for Bard Associates

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated